BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elbarky AM. Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE. Clin Ophthalmol 2020;14:823-30. [PMID: 32214793 DOI: 10.2147/OPTH.S238740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Elbarky A. Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in the UAE: 24 and 36-month outcomes. Eur J Ophthalmol 2022;:11206721221128671. [PMID: 36168254 DOI: 10.1177/11206721221128671] [Reference Citation Analysis]
2 Zarranz-Ventura J, Mali JO. Effectiveness of 190 µg Fluocinolone Acetonide and 700 µg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis. Clin Ophthalmol 2020;14:1697-704. [PMID: 32606585 DOI: 10.2147/OPTH.S253370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]